Collaborators

AFGen, or the Atrial Fibrillation Consortium, collaborates on work directed at trying identity the genetic basis of atrial fibrillation (AF).

The Center for the Development of Therapeutics (CDoT) is a highly collaborative organization of professional scientists who are eager to […]

The Framingham Heart Study is committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). It has followed CVD development over a long period of time in three generations of participants.  At Framingham, we have had a longstanding collaboration with Emelia Benjamin and Kathy Lunetta.

HERMES is an international collaboration to investigate the genetic basis of heart failure. This unique global effort currently comprises 51 population-based cohorts, […]

For the last decade, our laboratory has collaborated closely with Steve Lubitz’ lab at MGH and the Broad on a wide range of projects related to atrial fibrillation.

The Precision Cardiology Laboratory (PCL) of the Broad Institute and Bayer focuses on using innovative technologies to better understand cardiovascular disease and pursue new drug targets.

TIMI Study Group is an Academic Research Organization dedicated to advancing the knowledge and care of patients suffering from cardiovascular disease and its risk factors. At TIMI, we have collaborated with Drs. Marc Sabatine and Christian Ruff on a series of projects related to applying genetics to clinical trials data.

Nate is a former postdoc, faculty member and team lead for the Precision Cardiology Laboratory. In the spring of 2020, he started his own laboratory at the Masonic Medical Research Institute. Nate and Patrick continue to work together on multiple projects related to single cell sequencing for cardiovascular diseases.